# Anaptysbio, Inc: filings

ANAB · Nasdaq · CIK 1370053 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/anab.md) · [Financials](/companies/anab/financials.md) · [Filings](/companies/anab/filings.md) · [Insiders](/companies/anab/insiders.md)

## Reports and events: 187 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 266, 8-K 115, 144 68, SC 13G/A 38, 3 30, 10-Q 28, SC 13G 20, CORRESP 14, SCHEDULE 13G/A 13, 10-K 10, S-8 10, DEF 14A 9, DEFA14A 9, UPLOAD 9, S-1/A 8, SC 13D/A 7, SCHEDULE 13G 6, 424B5 5, D 5, ARS 4, EFFECT 4, SC 13D 3, 10-K/A 2, 10-Q/A 2, 424B4 2, DRS 2, S-1 2, S-3 2, 10-KT 1, 4/A 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, CT ORDER 1, DRS/A 1, DRSLTR 1, POS EX 1, PRE 14A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-21 | 20:20 ET | [8-K](/filings/0001193125-26-396690.md) | 9.01 Financial statements and exhibits | 0001193125-26-396690 |
| 2026-08-11 | 20:05 ET | [8-K](/filings/0001193125-26-344583.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-344583 |
| 2026-07-30 | 20:05 ET | [8-K](/filings/0001193125-26-326097.md) | 7.01 Regulation FD disclosure | 0001193125-26-326097 |
| 2026-06-29 | 20:05 ET | [DEF 14A](/filings/0001193125-26-288408.md) | Proxy statement, period 2026-06-29 | 0001193125-26-288408 |
| 2026-06-22 | 20:05 ET | [8-K](/filings/0001193125-26-277505.md) | 1.01 Entry into a material agreement | 0001193125-26-277505 |
| 2026-05-29 | 20:15 ET | [8-K](/filings/0001193125-26-248326.md) | 7.01 Regulation FD disclosure | 0001193125-26-248326 |
| 2026-05-21 | 20:10 ET | [8-K](/filings/0001193125-26-234419.md) | 5.03 Amendment to articles or bylaws | 0001193125-26-234419 |
| 2026-05-12 | 20:20 ET | [10-Q](/filings/0001193125-26-219515.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219515 |
| 2026-05-12 | 20:17 ET | [8-K](/filings/0001193125-26-219500.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219500 |
| 2026-05-11 | 20:05 ET | [8-K](/filings/0001193125-26-216745.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-216745 |
| 2026-04-28 | 20:10 ET | [10-K/A](/filings/0001193125-26-187044.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-187044 |
| 2026-04-24 | 20:17 ET | [8-K/A](/filings/0001193125-26-177317.md) | 9.01 Financial statements and exhibits | 0001193125-26-177317 |
| 2026-04-20 | 21:25 ET | [8-K](/filings/0001193125-26-164330.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164330 |
| 2026-03-27 | 13:19 ET | [8-K](/filings/0001193125-26-127783.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-127783 |
| 2026-03-03 | 21:23 ET | [10-K](/filings/0001193125-26-088290.md) | Annual report, period 2025-12-31 | 0001193125-26-088290 |
| 2026-03-03 | 21:16 ET | [8-K](/filings/0001193125-26-088239.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-088239 |
| 2026-01-09 | 22:17 ET | [8-K](/filings/0001370053-26-000002.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001370053-26-000002 |
| 2025-11-26 | 21:00 ET | [8-K](/filings/0001370053-25-000103.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001370053-25-000103 |
| 2025-11-21 | 14:01 ET | [8-K](/filings/0001370053-25-000097.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000097 |
| 2025-11-21 | 14:00 ET | [8-K](/filings/0001370053-25-000096.md) | 8.01 Other events | 0001370053-25-000096 |
| 2025-11-10 | 14:10 ET | [8-K](/filings/0001370053-25-000091.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000091 |
| 2025-11-04 | 21:19 ET | [10-Q](/filings/0001370053-25-000089.md) | Quarterly report, period 2025-09-30 | 0001370053-25-000089 |
| 2025-11-04 | 21:17 ET | [8-K](/filings/0001370053-25-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000088 |
| 2025-10-14 | 20:33 ET | [8-K](/filings/0001370053-25-000083.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001370053-25-000083 |
| 2025-09-29 | 20:29 ET | [8-K](/filings/0001370053-25-000081.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000081 |
| 2025-08-06 | 20:22 ET | [10-Q](/filings/0001370053-25-000064.md) | Quarterly report, period 2025-06-30 | 0001370053-25-000064 |
| 2025-08-06 | 20:20 ET | [8-K](/filings/0001370053-25-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000063 |
| 2025-06-17 | 20:05 ET | [8-K](/filings/0001370053-25-000055.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001370053-25-000055 |
| 2025-06-03 | 21:20 ET | [8-K](/filings/0001370053-25-000052.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001370053-25-000052 |
| 2025-05-05 | 20:19 ET | [10-Q](/filings/0001370053-25-000046.md) | Quarterly report, period 2025-03-31 | 0001370053-25-000046 |
| 2025-05-05 | 20:17 ET | [8-K](/filings/0001370053-25-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000045 |
| 2025-04-29 | 20:36 ET | [DEF 14A](/filings/0001370053-25-000038.md) | Proxy statement, period 2025-06-17 | 0001370053-25-000038 |
| 2025-03-24 | 13:20 ET | [8-K](/filings/0001370053-25-000028.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000028 |
| 2025-02-27 | 21:19 ET | [10-K](/filings/0001370053-25-000024.md) | Annual report, period 2024-12-31 | 0001370053-25-000024 |
| 2025-02-27 | 21:17 ET | [8-K](/filings/0001370053-25-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000023 |
| 2025-02-19 | 22:10 ET | [8-K](/filings/0001370053-25-000014.md) | 7.01 Regulation FD disclosure | 0001370053-25-000014 |
| 2025-02-12 | 13:30 ET | [8-K](/filings/0001370053-25-000010.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001370053-25-000010 |
| 2025-02-03 | 13:55 ET | [8-K](/filings/0001370053-25-000002.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure | 0001370053-25-000002 |
| 2024-12-11 | 21:06 ET | [8-K](/filings/0001370053-24-000067.md) | 8.01 Other events | 0001370053-24-000067 |
| 2024-11-05 | 21:19 ET | [10-Q](/filings/0001370053-24-000054.md) | Quarterly report, period 2024-09-30 | 0001370053-24-000054 |
| 2024-11-05 | 21:17 ET | [8-K](/filings/0001370053-24-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-24-000053 |
| 2024-08-16 | 16:07 ET | [SC 13D/A](/filings/0000935836-24-000533.md) | Ownership report, active investor, amended | 0000935836-24-000533 |
| 2024-08-14 | 20:43 ET | [8-K](/filings/0001193125-24-200684.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-200684 |
| 2024-08-05 | 20:22 ET | [10-Q](/filings/0001370053-24-000041.md) | Quarterly report, period 2024-06-30 | 0001370053-24-000041 |
| 2024-08-05 | 20:18 ET | [8-K](/filings/0001370053-24-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-24-000039 |
| 2024-06-12 | 20:05 ET | [8-K](/filings/0001370053-24-000029.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001370053-24-000029 |
| 2024-05-09 | 20:24 ET | [10-Q](/filings/0001370053-24-000027.md) | Quarterly report, period 2024-03-31 | 0001370053-24-000027 |
| 2024-05-09 | 20:20 ET | [8-K](/filings/0001370053-24-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-24-000026 |
| 2024-04-24 | 20:05 ET | [DEF 14A](/filings/0001370053-24-000019.md) | Proxy statement, period 2024-06-12 | 0001370053-24-000019 |
| 2024-03-11 | 20:36 ET | [10-K](/filings/0001370053-24-000011.md) | Annual report, period 2023-12-31 | 0001370053-24-000011 |

Page 1 of 4. [Older](/companies/anab/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.